Market Performance: IPO Demand Builds Steadily
The Gujarat Kidney and Super Speciality IPO continued to attract strong interest on the second day of bidding. By Tuesday afternoon, the issue had crossed the 2x subscription mark, showing rising participation across investor categories.
After a healthy response on Day 1, momentum clearly picked up on Day 2, reflecting growing attention around the healthcare IPO in the stock market today.
As of 12:40 PM on Tuesday, the numbers pointed to steady demand rather than a one-time spike.
Main News: Subscription Status on Day 2
The Rs 251-crore Gujarat Kidney and Super Speciality IPO received bids well above the shares on offer by the second day.
Here’s how the subscription stood:
- Total shares on offer: 1.32 crore
- Total bids received: 2.88 crore shares
- Overall subscription: 2.18 times
The IPO had already seen a solid start, with 1.47 times subscription on Day 1, and Day 2 data showed participation accelerating as the issue progressed.
Investor-Wise Subscription Breakdown
Interest was not evenly spread. Some categories stood out more than others.
- Retail Individual Investors (RII): 8.26 times
- Non-Institutional Investors (NII): 2.43 times
- Qualified Institutional Buyers (QIB): 34%
Retail participation remained the key driver, contributing the bulk of bids so far. Non-institutional investors also showed healthy engagement, while QIB participation was comparatively lower at this stage.
Anchor Investment Before the Issue
Before the IPO opened for public subscription, the company had already raised a little over Rs 100 crore from anchor investors.
This anchor placement provided early visibility and helped set the stage for the public issue, which later saw demand build across investor segments.
Issue Size, Price Band, and Timeline
The Gujarat Kidney and Super Speciality IPO follows a clearly defined structure and schedule.
- Issue size: Rs 251 crore
- Price band: Rs 108 to Rs 114 per share
- IPO closing date: December 24
Key upcoming dates:
- Allotment expected: December 26
- Proposed listing: December 30
- Stock exchanges: BSE and NSE
Use of IPO Proceeds
The company has clearly outlined how it plans to deploy the funds raised through the IPO.
The fresh issue proceeds are intended to be used for the following purposes:
- Acquisition of Parekhs Hospital in Ahmedabad
- Part payment for the already acquired Ashwini Medical Centre
- Setting up a new hospital in Vadodara
- Purchase of robotics equipment for the Vadodara facility
- Debt repayment
- Funding inorganic growth through unidentified acquisitions
- General corporate purposes
Each allocation aligns with expansion and consolidation within the healthcare space, as outlined in the offer details.
Company Overview: Gujarat Kidney and Super Speciality
Gujarat Kidney and Super Speciality Ltd operates in the regional healthcare space with a focused footprint.
Key highlights:
- Based in the central region of Gujarat
- Operates a chain of mid-sized multi-speciality hospitals
- Focus on secondary and tertiary healthcare
- Provides integrated healthcare services
The company’s operations are centered around delivering specialized medical care while expanding capacity through acquisitions and new hospital setups.
Summary: What the Day 2 Numbers Tell Us?
The Gujarat Kidney and Super Speciality IPO crossing 2x subscription on Day 2 signals growing participation as the issue moves toward closure.
- Subscription rose from 1.47x on Day 1 to 2.18x by mid-Day 2
- Retail investors remained the most active segment
- The IPO size stands at Rs 251 crore
- Funds are earmarked for hospital acquisitions, expansion, and debt reduction
As bidding continues until December 24, the IPO remains in focus within the stock market today, especially among investors tracking healthcare listings.
Source: Moneycontrol
Easy & quick
Leave A Comment?